Zacks Investment Management Axcella Health Inc. Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.16 - $1.1 $2,295 - $15,779	-14,345 Reduced 12.11%	104,124 $34,000
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $65,729 - $97,077	-14,446 Reduced 10.87%	118,469 $564,000
Q4 2020 Feb 16, 2021	SELL	$4.24 - $5.97 $149,642 - $210,699	-35,293 Reduced 20.98%	132,915 $690,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $5.91 $693,016 - $994,109	168,208 New	168,208 $777,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.